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Abstract 
Addition of (-)-Nα-tert-butoxycarbonyl-L-histidine methyl ester to diethyl fumarate 
regioselectively yielded diethyl 2-[4-(2-methoxycarbonyl-2-tert-butoxycarbonylaminoethyl) 
imidazol-1-yl] succinate as a 1:1 mixture of diastereomers. These compounds were identified by 
NMR using Eu(fod)3 as a stereospecific shift reagent, but were impossible to separate and 
characterise independently. Neutral hydrolysis of the mixture yielded the corresponding 
deprotected diastereomeric Nτ-(2-ethoxycarbonyl-1-carboxy)ethyl-L-histidine.. 
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Introduction 
 
We have previously described that 2-imidazol-1-ylsuccinic esters are easily prepared by 
nucleophilic addition of imidazole to fumaric esters.1 Their regioselective neutral hydrolysis 
yielded the corresponding half-esters which have been proved to be excellent extrinsic probes for 
the measurement of extracellular pH by in vitro 1H NMR.2 In fact, proton H-2 of imidazole ring 
of (±)-3-(ethoxycarbonyl)-2-imidazol-1-ylpropionic acid (IEPA) has been used to measure 
localized magnetic resonance spectroscopic imaging (MRSI) in mouse implanted tumours.3,4 
However, IEPA is a monocarboxylate ester and is efficiently cleared from the circulation across 
the kidney glomerulus by the monocarboxylate transporter. In order to increase the steady state 
IEPA levels, we have introduced another zwitterion in the structure that increases the polarity of 
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the molecule. In this communication we report the preparation of the corresponding L-histidine 
derivative (Scheme 1) in order to improve the properties that afford these kinds of compounds 
the capability to act like MRI functional contrast agents. 
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Scheme 1. Synthesis of (-)-Nτ-(2-ethoxycarbonyl-1-carboxyethyl)-L-histidine. 
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Results and Discussion 
 
Thermal addition of (-)-Nα-tert-butoxycarbonyl-L-histidine methyl ester to diethyl fumarate 
yielded regioselectively (-)-diethyl 2-[4-(2-methoxycarbonyl-2-tert-butoxycarbonylaminoethyl)-
imidazol-1-yl]succinate 3 as an unique regioisomer. The τ attachment of the chain was 
confirmed spectrometrically by COSY/NOESY analysis. Also, the coupling constants values of 
the imidazole protons are those described for τ substituted histidines.5 This regioselectivity is a 
remarkable feature because direct ring alkylation of histidine resulted in a mixture of τ and π 
derivatives.6 However, the addition reaction was not stereoselective7 and the new stereogenic 
center produced a mixture of diastereomers which were not differentiated by 1H or 13C NMR. 
Thus, spectra in CDCl3 of the mixture of both compounds, gave single signals for all nuclei. The 
diastereomers could only be resolved in the presence of a lanthanide shift reagent.8 Figure 1b 
depicted the split resonances of O-CH3 group in the presence of Eu(fod)39 that revealed a 50 % 
diastereomeric mixture of the two compounds obtained with the generation of a new stereogenic 
center. 
 
Figure 1. 1H NMR spectra in CDCl3 of diasteromers 3. 1a. Resonance of proton O-CH3 group. 
1b. Resonance of proton O- CH3 group in the presence of Eu(fod)3 0.5 L/S molar ratio. 
 
In the same way, studies performed by GC (using non-chiral and chiral columns) and HPLC 
(employing a ChiralPack OD column), showed only a single peak after the injection of the 
sample resulting from the addition of conveniently protected histidine to diethyl fumarate. The 
mixture of diastereomers could not be separated by column chromatography because they appear 
as a single spot in TLC chromatographs in all solvent mixtures, and always the sample put in on 
the column, was eluted as the same non enriched mixture in one diastereomer. 
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In the last step of the synthesis, the neutral hydrolysis1 of the succinate derivative yielded the 
half succinic ester and unexpectedly, the unprotected amino and acid groups of the histidine. 
This is a remarkable and very convenient result because this is an unusual and not previously 
reported deprotection method for these funtional groups. Cleavage of tert-butoxycarbonyl groups 
(BOC) are normally carried out in stronger conditions, with CF3COOH, either neat or in 
combination with CH2Cl210 Milder methods have been described with the assistance of 
microwaves11 or solid-phase12 methodologies. Additionally selective hydrolysis of methyl esters 
in the presence of ethyl esters can be conveniently achieved by treatment with LiI in pyridine13 
or with NaCN in HMPA14 The results obtained by us can be interpreted as a cascade hydrolytic 
process. Thus, it starts with the hydrolysis of the imidazolylacetate type ester in the histidyl 
succinate derivative, through a BAC3 mechanism.1 The presence of the succinic hemiester would 
promote a more acidic hydrolytic reaction of the methyl ester and BOC group. 
 
 
Experimental Section 
 
General Procedures. Melting points were obtained on a microscope hot stage and are 
uncorrected. Elemental analyses were performed with a Perkin-Elmer 240 apparatus. Optical 
rotations were measured in a 1 dm cell of 1 mL capacity using a Perkin-Elmer 241 polarimeter. 
NMR spectra were recorded with a Bruker AM-360 (360.13 MHz for 1H, 90.55 MHz for 13C) 
and a Bruker DRX-400 (400.13 MHz for 1H, 100.61 MHz for 13C). 1H and 13C chemical shifts 
(δ) in CDCl3 are given from internal tetramethylsilane.. 1H δ in D2O are given from internal 3-
(trimethylsilyl)tetradeuteropropionic acid sodium salt, and 13C in D2O are given from external 
DMSO-d6, with an accuracy of ± 0.01 ppm for 1H and ± 0.1 ppm for 13C. The residual water 
signal in 1H NMR spectra in D2O solutions was suppressed using a 1 s (low power, 0.5 watts) 
presaturating pulse applied with the decoupler. 1H-1H coupling constants (J) are accurate to ± 0.2 
Hz for 1H NMR spectra. AB and X parts refer to the ABX system formed by H-2 and H-3 
protons of 2-substituted succinic acid derivatives. TLC chromatography was performed on DC-
Alufolien/Kieselgel 60 F254 (Merck, 0.2 mm) and column chromatography through silica gel 
Merk 60 (70-230 mesh). The pK'a of the H-2 proton in compound 4 was determined by 1H NMR 
spectroscopy. pH Titration (22 oC) was performed using 25 mM solutions of the compound in 
D2O adjusting the pD with the addition of NaOD or DCl. Products were purchased from 
commercial sources and were used without additional purification. 
 
(-)-Nα-tert-Butoxycarbonyl-L-histidine methyl ester (2). To a solution of DMAP (2.391 g, 
19.6 mmol) in CH2Cl2 (20 mL) under argon, a solution of (+)-Nα-tert-butoxycarbonyl-L-
histidine (1) (5.000 g, 19.6 mmol) in CH3OH (20 mL) was added. The reaction mixture was 
cooled to 0 oC followed by a slow addition of a solution of DCC (3.861 g, 19.6 mmol) in CH2Cl2 
(10 mL).15 The reaction was stirred for 5 min at 0 oC, and left at room temperature for two days. 
Afterwards, the solvent was evaporated in vacuo and the residue was treated with CH2Cl2 to 
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precipitate DCU that was filtered off in vacuo. The remaining solution was concentrated in 
vacuo and the residue was purified through a silica gel column using CH2Cl2/EtOH: 95/5 as 
eluent to obtain 2 as a white solid (4.00 g, 75 %), mp 118-120 oC (from EtOH); [α]D20 = - 10° (c 
= 1, MeOH); IR (film) νmax/cm-1 3010, 2960, 1745 and 1710 (CO), 1510, 1380, 1070, 1040; 
δH(400.13 MHz; CDCl3; Me4Si) 1.42 (s, 9 H), 2.43 (s, 3 H), 3.09 (m, AB part, 2 H), 3.69 (s, 3 
H), 4.55 (m, X part, 1 H), 5.75 (m, 1 H, NH), 6.79 (bs, 1 H), 7.53 (bs, 1 H); δC(100.61 MHz; 
CDCl3; Me4Si) 28.3 (q), 29.7 (t), 52.3 (q), 53.6 (d), 116.3 (d), 133.7 (s), 135.2 (d), 155.6 (s), 
172.6 (s); m/z 196 (M+-73, 9 %), 152 (44), 136 (7), 110 (26), 82 (100), 81 (64), 57 (91). 
(-)-Diethyl 2-[4-(2-methoxycarbonyl-2-tert-butoxycarbonylaminoethyl)-imidazol-1-yl]succinate (3). 
A mixture of (-)-Nα-tert-butoxycarbonyl-L-histidine methyl ester (2) (1.425 g, 5.3 mmol) and 
diethyl fumarate (1.823 g, 10.6 mmol) was heated at 120 oC for 8 h. After cooling to room 
temperature, the residue was purified through a silica gel column using CH2Cl2/EtOH : 98/2 as 
eluent to obtain 1.730 g (74 %) of a brown oil (two diastereomers).as a mixture of 3a (50 %) and 
3b (50 %). Picrate mp 128-130 oC (from ethanol); [α]D20 = 17.0o (c = 1.5, CH2Cl2). Anal. Calcd 
for C26H34N6O15 (picrate): C, 46.56; H, 5.12; N, 12.53. Found: C, 46.71; H, 5.18; N, 12.54.; IR 
(film) νmax/cm-1 3050, 3010, 1745br (CO), 1505, 1380, 1180, 1070, 1040; δH(400.13 MHz; 
CDCl3; Me4Si) 1.22, (t, 3 H, J = 7,1 Hz)1.25 (t, 3 H, J = 7,1 Hz), 1.43 (s, 9 H), 2.85-3.25 (m, 2 
AB parts, 4 H), 3.68 (s, 3 H), 4.08 (m, 2 H), 4.17 (m, 2 H), 4.53 (X part, 1 H), 5.17 (X part, 1 H, 
J = 7.2 Hz), 5.82 (m, 1H), 6.74 (bs, 1 H), 7.46 (d, 1 H, J = 1.2 Hz); δC(100.61 MHz; CDCl3; 
Me4Si) 13.8 (q), 13.9 (q), 28.2 (q), 30.2 (t), 37.4 (t), 52.0 (q), 53.4 (d), 55.8 (d), 61.4 (t), 62.4 (t), 
79.5 (s), 115.4 (d), 136.8 (d), 138 (s), 155.5 (s), 168.2 (s), 169.0 (s), 172.3 (s); m/z (EI): 441 (M+, 
3%), 368 (12), 324 (50), 282 (32), 253 (65), 179 (11), 136 (12), 107 (32), 81 (57), 57 (100). 
(-)-Nτ-(2-Ethoxycarbonyl-1-carboxyethyl)-L-histidine (4). A solution of (-)-diethyl 2-[4-(2-
methoxycarbonyl-2-tert-butoxycarbonylaminoethyl)imidazol-1-yl]succinate (3a and 3b) (3.400 
g, 7.71 mmol) in distilled water (75 mL) was heated at 100 °C for 24 h. After cooling at room 
temperature, the reaction mixture was concentrated in vacuo to yield 1.850 g (80 %) of 4a and 
4b (1/1) as a white solid (two diastereomers); m.p. 195-197 °C, (from H2O /EtOH);  
[α]D20 = -7.6° (c = 1, MeOH). Anal. Calcd for C12H17N3O6.H2O: C, 45.56; H, 5.73; N, 13.28. 
Found: C, 45.56; H, 5.72 ; N, 13.26.; IR (KBr) νmax/cm-1 3457, 3138, 2980, 1726 and 1619bs 
(CO), 1593, 1519, 1402, 1333, 1249, 1156; δH(400.13 MHz; D2O; TSP) 1.15 (t, 3 H, J = 7.1 Hz), 
1.16 (t, 3 H, J = 6.9 Hz), 3.32-3.14 (m, 4 AB parts, 8 H), 3.97 (m, 2 X parts, 2 H), 4.10 (m, 4 H), 
5.29 (m, 2 X parts, 2 H), 7.46 (s, 2 H), 8.75 (s, 2 H); δc (100.61 MHz; D2O; TSP) 12.2 (q, 2 C), 
25.0 (t), 25.1 (t), 36.1 (t), 36.2 (t), 52.4 (d), 52.5 (d), 59.4 (d), 59.5 (d), 61.4 (t, 2 C), 119.0 (d), 
119.5 (d), 127.2 (s), 127.5 (s), 134.8 (d), 135.1 (d), 171.0 (s, 2 C), 171.5 (s, 4 C); m/z 254 (M+-
45, 3%), 143 (2), 127 (53), 117 (7), 99 (100), 82 (31), 71 (20), 55 (36); pKa' = 5.58. 
Determination of pKa'. The pKa' of the H-2 in componund 4 was determined by 1H NMR 
spectroscopy.2 pH Titration (37 oC) was performed using 25 mM solutions of the compound in 
D2O adjusting the required pD with the addition of NaOD or DCl. A different tube was used to 
obtain each pD value. The dependence of the H-2 chemical shift (δ) with respect to pD was 
obtained and computer fitted to the Henderson-Hasselbalch equation with the program Sigma 
Plot v 4.0.: 
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pD = pK'a – log [(δ-δ1) / (δ2-δ)] 
 
where δ1 and δ2 refer to the inferior (anionic) and superior (protonated) chemical shift limits of 
the titration curve. A three parameter, non-linear regression algorithm based on least squares 
minimization, allowed the determination of optimal value for δ1, δ2 and pKa’. Observed changes 
in the chemical shift of the H-2 proton are derived from the protonation/deprotonation at the 
imidazolic N-3 nitrogen atom. 
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